How much has Matchpoint Therapeutics raised?

Matchpoint Therapeutics has raised $250M across 2 sourced rounds on record. The latest is $150M (Series B+), announced October 7, 2026.

Who invested in Matchpoint Therapeutics?

Investors on record for Matchpoint Therapeutics: Access Biotechnology, Atlas Venture, BB Biotech, BOLD Longevity Growth Fund, Digitalis Ventures, Invus, Nextech Invest, Norwest Venture Partners and 2 others. Nextech Invest led its latest sourced round.

Where is Matchpoint Therapeutics based?

Matchpoint Therapeutics is based in Cambridge, United States and was founded in 2021.

Matchpoint Therapeutics

Matchpoint Therapeutics discovers precision small molecule medicines that use covalency to treat immune diseases and other serious illnesses. The company uses its Advanced Covalent Exploration platform, which integrates chemoproteomics, machine learning, and covalent chemistry library evolution. Matchpoint has an emerging pipeline of novel covalent medicines.

Health and bio Education

Matchpoint Therapeutics is a company based in Cambridge, United States, founded in 2021. Recent Funding lists it under Health and bio (also Education). It raised $150M in a Series B+ round in October 2026, led by Nextech Invest, according to bioworld.com. Recent Funding has 2 sourced rounds on record for it, totaling $250M, the first in October 2022. Investors on record include Access Biotechnology, Atlas Venture, BB Biotech, BOLD Longevity Growth Fund and 4 others. It was founded by Edward Chouchani, Jianwei Che, Nathanael Gray and 1 other.

Website: matchpointtx.com.

X: @matchpointtx · 134 followers.

LinkedIn: linkedin.com.

Categories: Health and bio Education.

Sectors: Biotechnology, Medical, Pharmaceutical.

Stage: Series B+.

Based in: Cambridge, United States.

Founded: 2021.

Total raised: $250M in 2 sourced rounds.

Last round: Oct 7, 2026 · 5 days ago.

Headcount: 11–50 employees.

X account age: 4 years.

Domain age: 4 years.

On Recent Funding since: Oct 8, 2026.

TIMELINE · MONEY RAISED

Matchpoint Therapeutics | 320 days from website to first raise on record

@matchpointtx·Raised $250M in 2 sourced rounds·2 signals before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

October 7, 2026
Series B+ · $150M
NNextech Invest (lead), NNorwest Venture Partners (lead), AAccess Biotechnology, AAtlas Venture, BBB Biotech, BBOLD Longevity Growth Fund, DDigitalis Ventures, IInvus, SSanofi Ventures, TT1D Fund
Source: bioworld.com
October 17, 2022
Series A · $100M
Source: citybiz
January 20, 2022
X account created
December 1, 2021
Website created

Founders and team

EC
Edward Chouchani Founder

@echouchani · LinkedIn · Founder profile
JC
Jianwei Che Founder

LinkedIn
NG
Nathanael Gray Founder

LinkedIn
TZ
Tinghu Zhang Founder

LinkedIn
GA
G. Andre Turenne President and CEO
JC
Jared Cumming Chief Scientific Officer

Investors

Matchpoint Therapeutics: questions and answers

How much has Matchpoint Therapeutics raised?: Matchpoint Therapeutics has raised $250M across 2 sourced rounds on record. The latest is $150M (Series B+), announced October 7, 2026.
Who invested in Matchpoint Therapeutics?: Investors on record for Matchpoint Therapeutics: Access Biotechnology, Atlas Venture, BB Biotech, BOLD Longevity Growth Fund, Digitalis Ventures, Invus, Nextech Invest, Norwest Venture Partners and 2 others. Nextech Invest led its latest sourced round.
Who founded Matchpoint Therapeutics?: Matchpoint Therapeutics was founded by Edward Chouchani, Jianwei Che, Nathanael Gray and Tinghu Zhang.
Where is Matchpoint Therapeutics based?: Matchpoint Therapeutics is based in Cambridge, United States and was founded in 2021.